https://www.selleckchem.com/pr....oducts/nedometinib.h
GA/FG-C18 NMs showed a larger area under the curve (AUC) and mean residence time (MRT) compared with free GA after intravenous administration in mice. The in vivo studies showed that GA mainly accumulated in the liver after encapsulation by FG-C18 NMs, and the drug concentration was higher than that of free GA. These results suggested that FG-C18 NMs could serve as a potential drug delivery system for targeting GA to liver tissue.US Food and Drug Administration adverse event data for 2019 were analyzed for two insulin pumps and two
Gefällt mir
Kommentar
Teilen
